MOREPEN LABORATORIES
Back to Cashflow Statement
|
MOREPEN LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹300 Cr | ₹5.20 Cr | ₹144 Cr | ₹66 Cr | ₹47 Cr |
What is the latest Cash Flow from Financing Activities ratio of MOREPEN LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹300 Cr |
| Mar2024 | ₹5.20 Cr |
| Mar2023 | ₹144 Cr |
| Mar2022 | ₹66 Cr |
| Mar2021 | ₹47 Cr |
How is Cash Flow from Financing Activities of MOREPEN LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹300 Cr | 5,661.50 | |
| Mar2024 | ₹5.20 Cr | -96.37 | |
| Mar2023 | ₹144 Cr | 116.39 | |
| Mar2022 | ₹66 Cr | 40.32 | |
| Mar2021 | ₹47 Cr | - | |
Compare Cash Flow from Financing Activities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹4,213.6 Cr | 14.5% | 29.5% | 38.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,471.0 Cr | -0.4% | 0.9% | 19.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,631.0 Cr | -1.2% | 21.1% | 29.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,157.0 Cr | -2.3% | 0.3% | 34.8% | Stock Analytics | |
| CIPLA | ₹118,108.0 Cr | 0.7% | 1.5% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,578.0 Cr | -0.3% | -7.1% | -3.9% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | 14.5% |
29.5% |
38.7% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses